Mammography Reminders for Encouraging Women to Undergo Regular Mammography Screenings for Breast Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01148875|
Recruitment Status : Completed
First Posted : June 22, 2010
Last Update Posted : January 20, 2016
RATIONALE: Mammography reminders may encourage women to undergo regular mammography screenings for breast cancer.
PURPOSE: This randomized clinical trial is studying three different mammography reminder interventions to compare how well they work in encouraging women to undergo regular mammography screenings for breast cancer.
|Condition or disease||Intervention/treatment|
|Breast Cancer||Behavioral: Mammography appointment reminders; telephone counseling|
- Compare the effectiveness of mammography reminder interventions using usual care reminder vs enhanced automated phone reminder vs enhanced letter reminder in increasing the proportion of women who undergo annual mammograms as recommended by medical organizations.
- Compare the impact of alternative delivery channels (mail vs automated phone reminders) and enhanced messages in facilitating maintenance of mammography in these participants.
- Determine the incremental benefit of adding a consequence elaboration component to barriers-specific telephone counseling in encouraging these participants to regain adherence to mammography.
- Determine the minimum intervention needed for change to ensure annual mammography and maintenance in participants.
OUTLINE: This is a randomized, controlled study. Participants are randomized to 1 of 3 arms.
- Arm I: Participants receive a usual care mammography reminder by telephone annually for 4 years.
- Arm II: Participants receive an enhanced automated phone mammography reminder annually for 4 years.
- Arm III: Participants receive an enhanced letter mammography reminder annually for 4 years.
Insurance claims reports and patients' self reports as to whether or not they subsequently underwent mammography are examined. Patients who do not undergo mammography within 6 months after receiving a reminder are further randomized to 1 of 4 arms.
- Arm I: Participants receive no further reminders until the next annual reminder.
- Arm II: Participants receive an enhanced Barriers-Specific Counseling Call (BarriConCall) annually for 4 years that focuses on positive consequences of undergoing mammography.
- Arm III: Participants receive an enhanced BarriConCall annually for 4 years that focuses on negative consequences of not undergoing mammography.
- Arm IV: Participants receive a standard barrier call (BarriCall) annually for 4 years.
PROJECTED ACCRUAL: A total of 4,040 participants (1,000 for usual care mammography reminder; 1,520 for enhanced automated phone mammography reminder; and 1,520 for enhanced letter mammography reminder) will be accrued for this study.
|Study Type :||Observational|
|Actual Enrollment :||3547 participants|
|Official Title:||Finding the M.I.N.C. for Mammography Maintenance|
|Study Start Date :||September 2004|
|Actual Primary Completion Date :||October 2010|
|Actual Study Completion Date :||October 2010|
Behavioral: Mammography appointment reminders; telephone counseling
- Usual Care Reminder(UCR)
- Enhanced Automated Phone Reminder (EAPR)
- Enhanced Letter Reminder (ELR)
- Priming Letter (PL)
- Mammography Adherence [ Time Frame: 12 months ]The primary study objective was to identify the minimal intervention needed for sustained mammography adherence over 4 years. Average cumulative number of days non-adherent to mammography over 4 years based on annual screening guidelines. Claims data (monthly mammography claims information were reviewed to determine women's adherence status) and self-report (during annual telephone interviews, women were asked to confirm dates of their most recent and prior mammograms, based on claims data) were used to determine dates of screening.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01148875
|Principal Investigator:||Barbara K. Rimer, PhD||UNC Lineberger Comprehensive Cancer Center|